UPH
Dược phẩm TW 25 ·UPCOM ·2026Q1
▼ Under pressure
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, UPH is declining across multiple metrics versus the same period, suggesting current pressure is not coming from just one side — profit momentum has been slowing across consecutive periods. More notably, a significant portion of profit is supported by non-core sources, further affecting earnings quality.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.0 | 46.7 | 26.9 | 20.5 | 18.8 | 46.7 | 24.4 | 29.9 | 29.6 | 40.2 | 27.8 | 42.9 |
| Growth | -44% | +73% | +31% | +9% | -60% | +91% | -18% | +1% | -26% | +45% | -35% | — |
| Net Income | 0.6 | 1.6 | 0.5 | -0.1 | 0.3 | 1.2 | 0.4 | 0.9 | 0.6 | 0.7 | 0.4 | 0.6 |
| Net Margin | 2.14% | 3.38% | 1.89% | -0.53% | 1.53% | 2.58% | 1.44% | 2.99% | 2.09% | 1.78% | 1.54% | 1.48% |
Drivers of UPH's profit
Net profit attributable to parent declined vs last year, mainly due to higher administrative expenses. Supporting and offsetting drivers:
Net profit attributable to parent increased vs prior quarter, mainly helped by higher gross profit. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE is broadly flat at 1.6% — the components are offsetting one another.
Is the profit sustainable?
Margins are under pressure while earnings still rely significantly on non-core sources.
What is driving the margin?
Net margin stands at 2.11%, broadly flat versus the same period. Supportive factors and pressure points are offsetting one another.
Margin is nearly flat but the underlying components are moving — this is a transitional phase, more time is needed to see the real trend.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Watchpoints
Margin support from financial result remains high (74.6% of PBT) — sustainability should be monitored.
Is capital being used efficiently?
Evaluate capital, asset, and working-capital efficiency.
Balance Sheet
Balance sheet is exceptionally sound — liabilities at 1.46x equity, with a net cash position equivalent to 0.21x equity.
Inventory ended the period at 191.3bn, roughly 49.3% of total assets.
Over the last 12 months, working capital released 0.1bn of cash, mainly thanks to lower inventories and higher payables. Pressure from higher receivables only partly offset that benefit.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 6.2 days versus the same period last year. The main moves came from DIO rose 21.2 days, DSO fell 13.8 days, and DPO rose 13.7 days.
Improvement comes mainly from faster inventory turnover — watch whether this trend persists in coming periods.
Watchpoints
CCC stands at 795.7 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DIO increased by +21.2 days, suggesting more capital is being tied up in inventories.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Financial risk is low — the company has net cash and CFO reached 7.5bn.
Leverage & Liquidity
Track net leverage, interest coverage, and the liquidity buffer on the balance sheet.
Debt maturity and the cash buffer remain the two key areas to monitor.
Some leverage signals are missing, so the current read should be treated as contextual.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 7.5bn in 2025, against investing cash flow of 13.6bn.
Post-investment cash flow was positive +21.1bn. Financing cash flow was positive 0.0bn.
CFO / net income was 1.36x.
After spending +0.5bn on fixed-asset investment, the business generated trailing free cash flow of +2.9bn.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is showing a brighter picture at the headline-earnings level, but what deserves a closer look right now is the quality of that improvement. Margins and net profit may look better, but if financial income, other income, or unusually low taxes contribute too much, this is not yet a clean enough growth base to extrapolate further. The main bright spot is balance-sheet flexibility, with net cash/equity at about -0.21x. Even so, the earnings mix still warrants monitoring in upcoming periods, when non-core contribution is 74.6%. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 796 days.
Improvement: the balance sheet remains flexible, with a net cash position equivalent to 0.21x of equity.
Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 1.36x. Even so, net financial result still accounts for 74.6% of PBT, so the earnings mix still needs monitoring.
Key risk: working capital remains tied up for too long, with cash cycle at 795.7 days.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
113.0 | 130.6 | 140.1 | 150.2 | 166.3 |
|
Cost of Goods Sold
|
98.5 | 113.5 | 121.9 | 128.7 | 0.0 |
|
Gross Profit
|
14.5 | 17.0 | 18.3 | 21.5 | 19.6 |
|
Financial Expenses
|
0.0 | 0.0 | 0.0 | 0.2 | -0.4 |
|
Selling Expenses
|
1.2 | 2.3 | 4.1 | 4.9 | -15.2 |
|
General and Administrative Expenses
|
12.9 | 14.3 | 14.4 | 15.9 | -12.2 |
|
Operating Profit
|
2.8 | 2.6 | 2.3 | 1.9 | -7.0 |
|
Profit Before Tax
|
2.9 | 2.6 | 2.2 | 2.0 | -7.3 |
|
Net Income
|
2.3 | 3.1 | 2.2 | 2.1 | -7.2 |
|
Profit Attributable to Parent
|
2.3 | 3.1 | 2.2 | 2.1 | -7.2 |
|
Earnings per Share
|
170.00 | 231.00 | 166.00 | 156.00 | -544.56 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.